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increase concentration 10%, 15%, 20% and 25% within 24 to 48 hours after contrast
media exposure was detected in 47 patients (17.67%), 35 patients (13.16%), 24
patients (9.02%) and 16 patients (6.02%), respectively. By logistic regression analysis,
the independent predictor of major adverse events was cutoffs deﬁned as increase in
CyC 10% or sCr 25% (odds ratio3.89; 95% conﬁdence interval, 1.20 to 12.54;
P¼0.02).
Conclusions: In patients undergoing percutaneous coronary intervention,
cystatin C in combined with creatinine seems to be a reliable marker for the early
diagnosis of contrast-induced acute kidney injury, and an independent predictor of
MACEs.GW25-e2330
Accelerated endothelialization with a CD105 antibody-coated stent
Cui Song1, Jing-Hua Liu1, Xian-Tao Song1, Chao Ding2, Li-Jun Meng3,
Shuzheng-Lv1
1The Key Laboratory of Remodeling-related Cardiovascular Diseases, Department of
Cardiology, 2Department of Cardiology, Huimin County People’s Hospital, Binzhou
251700, China, 3Department of Cardiology, Binzhou Central Hospital, Binzhou
251700, China
Objectives: Endoglin/CD105 is an accessory protein of the transforming growth
factor-b receptor system that plays a critical role in proliferation of endothelial cells
and neovasculature. Here, we aimed to assess the effect of novel stents coated with
antibodies to endoglin (ENDs) on coronary neointima formation.
Methods: Thirty ENDs, thirty CD34 stents (CD34s), thirty sirolimus-eluting stents
(SESs), and thirty bare metal stents (BMSs) were randomly assigned and placed in the
coronary arteries in 40 juvenile pigs. Histomorphometric analysis and scanning
electron microscopy were performed after stent implantation.
Results: Our results showed that after 7 days, there was no difference in the neo-
intimal area and percent area stenosis in ENDs compared with CD34s or SMSs or
BMSs. After 14 days, the neointima area and percent area stenosis in ENDs and
CD34s and SESs were markedly decreased than those in BMSs (P<0.05). Moreover,
the percentage of reendothelialization was signiﬁcantly higher in ENDs and CD34s
than that in SESs or BMSs (P<0.05) at 7 and 14 days. There was no difference in the
neointima area and percent area stenosis and percentage of reendothelialization in
ENDs compared with CD34s. The artery injury and the inﬂammationscores were
similar in all groups at 7 and 14 days.
Conclusions: In conclusion, similar to CD34s,our results demonstrated for the ﬁrst
time to our knowledge that endoglin antibody-coated stents can markedly reduce
restenosis by enhancing reendothelialization in the porcine model and potentially offer
a new approach to prevent restenosis.GW25-e2475
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Objectives: To evaluate the safety and efﬁcacy of l-carnitine in prevention of contrast-
induced nephropathy (CIN) in coronary heart disease (CHD) patients with diabetes
mellitus (DM) undergoing percutaneous coronary intervention and assess the value of
determination of urine kidney injury molecule-1 (KIM-1) protein concentration in the
early diagnosis of CIN.
Methods: A single-center prospective randomized controlled trial was performed,
145 CHD patients with DM were divided randomly into groups control (n¼73,
receiving only 0.9% sodium chloride solution for routine hydration) and
intervention (n¼72, based on routine hydration receiving l-carnitine 3.0 g to join
saline 250 ml of intravenous infusion in 0.9% sodium chloride 3d before opera-
tion, and on day l,2,respectively,after operation).All entrants in surgery on regular
check. The renal function of all patients were accessed before and 1-2 days after
operation. And 15ml urine was collected before and 2h,6h,12h,24h,48h after
operation and centrifuged at 3,000r/min in 4C for 20 minters then 1 ml super-
natant was collected which stored in -80C Ultra-low temperature freezer until
use. Urine KIM-1 level was measured by Enzyme-linked immunosorbent assay
(ELISA).
Results: The two groups were well matched for baseline characteristics, the
average amount of contrast medium during operation. There were 19 cases of
CIN of the 145 patients (13.1%). The incidence of CIN was 19.2% (14/73) in
sodium chloride group while 6.9% (5/72) in l-carnitine group. The incidence of
contrast-induced nephropathy was lower in l-carnitine group than in control, but
the difference was signiﬁcant (6.9% vs 19.2%, P <0.05).There was a signiﬁcant
difference (P <0.05) between the urine KIM-1 level of 2, 6, 12, 24, 48 h
(4015.83855.96, 5095.321235.09, 5982.041506.02, 6984.201441.87,
6078.811519.56) pg/ml after operation and the urine KIM-1 level
(3515.98954.58) pg/ml before operation. There was not a signiﬁcant difference
between the Scr level at 24h after operation and before the operation. CIN can beC142 JACC Vol 64/16/Suppl C j October 16–1diagnosed by urine KIM-1 at least 24h ahead Scr. The area under the ROC curve
of urine KIM-1 24h after operation is 0.856, conﬁdence interval of AUC 95% is
(0.782,0.929). If the critical point of the diagnosis of CIN by the urine KIM-1 is
6327.755pg/ml, the sensitivity is 73.7% and the speciﬁcity is 85.7%. Bivariate
shows that the level of KIM-1 before and 24,48h after operation positively
correlated with Scr at the same time. Binary logistic regression shows: advanced
age, left heart insufﬁciency, high does of contrast agent before operation are the
independent risk facts of CIN.
Conclusions: Short-term application of l-carnitine has the trend of lowering contrast-
induced nephropathy in CHD patients with DM. The results show that urinary KIM-1
levels can be used as an indicator for early diagnosis of CIN.GW25-e2520
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Objectives: Percutaneous coronary intervention (PCI) of ostial lesions is complex and
is technically very demanding. Intravascular ultrasound (IVUS) is considered the gold
standard method to guide PCI but has several limitations. Stent Boost Subtract (SBS)
imaging is an enhancement of the radiologic edge of the stent by digital management
of regular X-ray images. The purpose of this study is to determine the availability of
stent enhancement with SBS during ostial PCI by comparison with intravascular
IVUS.
Methods: We investigated SBS and IVUS after stent implantation in 58 ostial lesions
in 55 patients. Ostial lesions included both native aorto-ostial or major coronary vessel
lesions. SBS and IVUS was performed in all patients to obtain improved stent location
and to detect optimal release and deployment.
Results: We deﬁned the SBS and IVUS criteria for adequate stent deployment. IVUS
ﬁndings showed inadequate stent deployment in 10/58 observations (17.2%). Eight
SBS images showed inadequate stent expansion. SBS predicted inadequate ﬁndings of
IVUS with 100% speciﬁcity, 80% sensitivity, meanwhile, a signiﬁcant positive cor-
relation was observed between SBS-MSA and MSA by IVUS with a regression
coefﬁcient of 0.95.
Conclusions: Imaging techniques have a primary role during ostial PCI. SBS is a
simple and quick method that offers several advantages, enabling improved stent
location, adequate stent expansion and optimal apposition of the struts to the wall.
SBS imaging could be conventionally used during ostial PCI, especially in centers
where IVUS is not used routinely.GW25-e3414
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Objectives: To observe the characteristics of coronary artery lesion in patients with
unstable and stable angina by virtual histology intravascular ultrasound.
Methods: A total of 199 patients with angina pectoris were enrolled in our study, they
were divided into stable angina group (101 cases) and unstable angina pectoris group
(98 cases) according to clinical symptoms, ECG and myocardial enzyme. Coronary
angiography to determine the “criminals” vessels. Comparison of the coronary artery
lesions’ indicators in minimal lumen area measured by grayscale and virtual histology
intravascular ultrasound were made between the unstable angina group and stable
angina group respectively. Grayscale intravascular ultrasound index: external elastic
membrane (EEM), lumen cross-sectional area (LA), plaque area (PA), plaque burden
(PB), remodeling index (RI), plaque eccentricity index (EI) ;Virtual histology intra-
vascular ultrasound index: the plaque composition of calciﬁed tissue, ﬁbrous tissue,
lipid tissue and necrotic tissue.
Results: Two sets of results at the external elastic membrane area, lumen area, plaque
area, eccentricity index, remodeling index have no signiﬁcant difference (t¼1.392,
-.0345, 1.921, 0.378, 0.857, P>0.05). Compared with stable angina group, unstable
angina pectoris group in minimal lumen area have larger external elastic membrane
area, smaller lumen area, greater plaque area, the greater the eccentric index and
remodeling index. Necrotic core (red) area and percentage of lesion composition in
unstable angina group was signiﬁcantly higher than that instable angina group
(t¼2.361, 2.418 P<0.05). Two sets of results at lipid and calciﬁcation area and plaque
distribution percentage have no statistically signiﬁcant differences (t¼1.045, 1.884,
0.787, P>0.05).
Conclusions: Necrotic core area and percentage of plaque composition in the unstable
angina group is larger. “Criminals” lesions are more unstable and more easily
complicated with acute cardiovascular events.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
